Can non-invasive electrical brain stimulation improve exercise rehabilitation outcomes in people with hip osteoarthritis?

Not Applicable

• Conditions: Osteoarthritis; Musculoskeletal - Osteoarthritis

• Registration Number: ACTRN12624000129583
• Lead Sponsor: Edith Cowan University, 270 Joondalup Drive, Joondalup, WA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-02-13
• Last Update Posted: 19 February 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Clinical and radiological diagnosis of hip OA will be undertaken (includes accounting for dropouts). The clinical and radiological diagnosis will be made via a Sports and Exercise Physician. The clinical diagnosis includes activity-related hip pain (>3/10) and positive Flexion Adduction and Internal Rotation (FADDIR) tests. Radiological OA will be categorised as a Kellgren Lawrence score of greater than or equal to 2.

Exclusion Criteria

Rehabilitation in past 6-months; previous lower-limb surgery; hip joint injection within 3 months; neurological conditions; cardiometabolic conditions that preclude exercise; inability to commit to rehabilitation; specific transcranial magnetic stimulation and tDCS (Pregnancy; Neurological conditions/illness, including epilepsy/convulsion/seizure
Vascular, traumatic, tumorous, infectious, or metabolic lesion of the brain, even without history of seizure, and without anticonvulsant medication; previous or current implants in their body that may be triggered or heated by an electrical current (e.g. pacemaker, intracranial shunts, artificial cochlea, etc); Any mental implanted in their head (e.g. surgical clips, staples, shrapnel); Frequent or intense headaches; Previous brain trauma or neurosurgical intervention Serious medical complications (e.g. advanced pulmonary, cardiac, liver or kidney disease) or CPM contraindications (Cold urticaria; Raynaud’s phenomenon); inability to understand English.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain[The International Hip Outcome Tool–33 (iHOT-33) Baseline and then 4, 8 and 16 weeks post baseline. ];Disability[The International Hip Outcome Tool–33 (iHOT-33) Baseline and then 4, 8 and 16 weeks post baseline. ]